Serum expression of SSA and SSB autoantibodies is observed in ~25-75% of SjD patients (44, 45), respectively, but are also detected in patients with systemic lupus erythematosus and rheumatoid arthritis (9, 46). This evidence concerns the gene TRIM21 and rheumatoid arthritis.